CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 8.61: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.93%Below 5Y avg (2.45%)
Annual Rate
CNY 0.18Paid annual
Payout Ratio
65.4%Moderate
Payback Period
51.8 yr
Last Ex-Dividend
Jun 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.19BCNY622.54M · vs all stocks (USD)
Trailing P/E
18.56xRevenue (TTM)
1.16BCNY172.81M · vs all stocks (USD)
Profit Margin
18.64%Beta
-0.0870xvs all stocks
52-Week Change
-27.66%vs all stocks
Market Capitalization
4.19BCNY622.54M · vs all stocks (USD)
Enterprise Value
2.97BCNY441.87M · vs all stocks (USD)
Trailing P/E
18.56xForward P/E
10.43xPrice to Sales (TTM)
3.48xPrice to Book (MRQ)
2.60xEnterprise to Revenue
2.56xEnterprise to EBITDA
11.85xGross Margin
60.19%Profit Margin
18.64%Operating Margin
23.99%Return on Assets (TTM)
6.76%Return on Equity (TTM)
14.37%Revenue (TTM)
1.16BCNY172.81M · vs all stocks (USD)
Revenue per Share (TTM)
2.69CNYUpdated Aug 21, 2026Quarterly Revenue Growth
8.90%Gross Profit (TTM)
710.22MCNY105.62M · vs all stocks (USD)
EBITDA (TTM)
295.30MCNY43.91M · vs all stocks (USD)
Net Income (TTM)
216.65MCNY32.22M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-19.20%Operating Cash Flow (TTM)
223.03MCNY33.17M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
68.82MCNY10.23M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1800CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
1.93%vs all stocks
5-Year Average Dividend Yield
2.45%vs all stocks
Payout Ratio
65.40%Revenue
1.14BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
437.81MCNYFY2025 · Dec 31, 2025Gross Profit
697.94MCNYFY2025 · Dec 31, 2025Operating Income
259.34MCNY38.57M · vs all stocks (USD)
Pre-tax Income
283.60MCNYFY2025 · Dec 31, 2025Income Tax Expense
50.75MCNYFY2025 · Dec 31, 2025Net Income
232.85MCNYFY2025 · Dec 31, 2025EBIT
283.83MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
318.79MCNYFY2025 · Dec 31, 2025Research & Development
110.62MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
206.95MCNYFY2025 · Dec 31, 2025Other Operating Expenses
12.31MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
1.55MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
224.60KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.5400CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.5400CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
431.21MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
431.21MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
232.85MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
246.25MCNYFY2025 · Dec 31, 2025Free Cash Flow
162.34MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
212.22MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
232.85MCNYFY2025 · Dec 31, 2025Other Non-cash Items
1.61MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
8.29MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
3.49MCNYFY2025 · Dec 31, 2025Capital Expenditures
-83.91MCNYFY2025 · Dec 31, 2025Sale of Investments
29.06MCNYFY2025 · Dec 31, 2025Other Investing Activity
34.10MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-20.75MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-163.44MCNYFY2025 · Dec 31, 2025Other Financing Charges
-4.02MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-167.45MCNYFY2025 · Dec 31, 2025Shares Outstanding
435.16MSharesUpdated Aug 21, 2026Float Shares
95.77MSharesUpdated Aug 21, 2026% Held by Insiders
78.27%vs all stocks
% Held by Institutions
0.09%vs all stocks
Total Cash (MRQ)
1.05BCNY156.52M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.44CNYUpdated Aug 21, 2026Total Debt (MRQ)
11.81MCNY1.76M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0076xCurrent Ratio (MRQ)
3.74xBook Value per Share (MRQ)
3.57CNYUpdated Aug 21, 2026Total Assets
1.87BCNY277.62M · vs all stocks (USD)
Total Current Assets
1.29BCNYFY2025 · Dec 31, 2025Total Liabilities
390.49MCNYFY2025 · Dec 31, 2025Total Non-current Assets
577.94MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
42.18MCNYFY2025 · Dec 31, 2025Total Current Liabilities
348.31MCNYFY2025 · Dec 31, 2025Cash
212.22MCNYFY2025 · Dec 31, 2025Cash Equivalents
0.00CNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
212.22MCNYFY2025 · Dec 31, 2025Other Short-term Investments
770.00MCNYFY2025 · Dec 31, 2025Accounts Receivable
131.58MCNYFY2025 · Dec 31, 2025Inventory
59.82MCNYFY2025 · Dec 31, 2025Accounts Payable
217.26MCNYFY2025 · Dec 31, 2025Short-term Debt
3.97MCNYFY2025 · Dec 31, 2025Other Current Liabilities
831.27KCNYFY2025 · Dec 31, 2025Long-term Debt
7.23MCNYFY2025 · Dec 31, 2025Common Stock (Book)
435.16MCNYFY2025 · Dec 31, 2025Retained Earnings
613.23MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.48BCNY219.55M · vs all stocks (USD)
Treasury Stock
30.00MCNYFY2025 · Dec 31, 202552-Week Low
7.82CNYUpdated Aug 21, 202652-Week High
13.49CNYUpdated Aug 21, 202652-Week Change
-27.66%vs all stocks
Beta
-0.0870xvs all stocks
50-Day MA
8.82CNYUpdated Aug 21, 2026200-Day MA
10.27CNYUpdated Aug 21, 2026Avg 10-Day Volume
3.27MSharesUpdated Aug 21, 2026Avg 30-Day Volume
2.80MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.5000CNYUpdated Aug 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 8.61: safe zoneNotable
Altman Z-Score: 8.61
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Shanghai Kinetic Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hangzhou AGS Medtech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Kexing Biopharm Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
TTY Biopharm Company Limited
Tier 1ProductionApproval-Gated PipelineRule
Cerus Corporation
Tier 1ProductionApproval-Gated PipelineRule
Jinling Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Beijing Scitop Bio-Tech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Allogene Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Tectonic Therapeutic Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Hainan Shuangcheng Pharmaceuticals Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Hubei Jumpcan Pharmaceutical Co., Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
CIE Automotive India Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Manhattan Associates Inc.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities